Where does parkinson disease pathology begin in the brain? - PubMed (original) (raw)
Where does parkinson disease pathology begin in the brain?
Kelly Del Tredici et al. J Neuropathol Exp Neurol. 2002 May.
Abstract
The substantia nigra is not the induction site in the brain of the neurodegenerative process underlying Parkinson disease (PD). Instead, the results of this semi-quantitative study of 30 autopsy cases with incidental Lewy body pathology indicate that PD in the brain commences with the formation of the very first immunoreactive Lewy neurites and Lewy bodies in non-catecholaminergic neurons of the dorsal glossopharyngeus-vagus complex, in projection neurons of the intermediate reticular zone, and in specific nerve cell types of the gain setting system (coeruleus-subcoeruleus complex, caudal raphe nuclei, gigantocellular reticular nucleus), olfactory bulb, olfactory tract, and/or anterior olfactory nucleus in the absence of nigral involvement. The topographical parcellation of the nuclear grays described here is based upon known architectonic analyses of the human brainstem and takes into consideration the pigmentation properties of a few highly susceptible nerve cell types involved in PD. In this sample and in all 58 age- and gender-matched controls, Lewy bodies and Lewy neurites do not occur in any of the known prosencephalic predilection sites (i.e. hippocampal formation, temporal mesocortex, proneocortical cingulate areas, amygdala, basal nucleus of Meynert, interstitial nucleus of the diagonal band of Broca, hypothalamic tuberomamillary nucleus).
Comment in
- Controversies over the staging of alpha-synuclein pathology in Parkinson's disease.
Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK. Kalaitzakis ME, et al. Acta Neuropathol. 2008 Jul;116(1):125-8; author reply 129-31. doi: 10.1007/s00401-008-0381-3. Epub 2008 Apr 30. Acta Neuropathol. 2008. PMID: 18446352 No abstract available.
Similar articles
- alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.
Braak E, Sandmann-Keil D, Rüb U, Gai WP, de Vos RA, Steur EN, Arai K, Braak H. Braak E, et al. Acta Neuropathol. 2001 Mar;101(3):195-201. doi: 10.1007/s004010000247. Acta Neuropathol. 2001. PMID: 11307617 - Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system.
Braak H, Rüb U, Sandmann-Keil D, Gai WP, de Vos RA, Jansen Steur EN, Arai K, Braak E. Braak H, et al. Acta Neuropathol. 2000 May;99(5):489-95. doi: 10.1007/s004010051150. Acta Neuropathol. 2000. PMID: 10805091 - Olfactory pathogenesis of idiopathic Parkinson disease revisited.
Lerner A, Bagic A. Lerner A, et al. Mov Disord. 2008 Jun 15;23(8):1076-84. doi: 10.1002/mds.22066. Mov Disord. 2008. PMID: 18442121 - [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C, Hauw JJ. Duyckaerts C, et al. Bull Acad Natl Med. 2003;187(2):277-92; discussion 292-3. Bull Acad Natl Med. 2003. PMID: 14556441 Review. French. - [Postmortal diagnosis of Parkinson's disease].
Sandmann-Keil D, Braak H. Sandmann-Keil D, et al. Pathologe. 2005 May;26(3):214-20. doi: 10.1007/s00292-004-0722-5. Pathologe. 2005. PMID: 15538572 Review. German.
Cited by
- Olfactory Dysfunction in Parkinson's Disease, Its Functional and Neuroanatomical Correlates.
Torres-Pasillas G, Chi-Castañeda D, Carrillo-Castilla P, Marín G, Hernández-Aguilar ME, Aranda-Abreu GE, Manzo J, García LI. Torres-Pasillas G, et al. NeuroSci. 2023 Jun 5;4(2):134-151. doi: 10.3390/neurosci4020013. eCollection 2023 Jun. NeuroSci. 2023. PMID: 39483318 Free PMC article. Review. - Subjective cognitive and olfactory impairments predict different prospective dementia outcomes.
Cedres N, Olofsson JK. Cedres N, et al. Chem Senses. 2024 Jan 1;49:bjae033. doi: 10.1093/chemse/bjae033. Chem Senses. 2024. PMID: 39298281 Free PMC article. - Simulating combined monoaminergic depletions in a PD animal model through a bio-constrained differential equations system.
Carli S, Brugnano L, Caligiore D. Carli S, et al. Front Comput Neurosci. 2024 Aug 23;18:1386841. doi: 10.3389/fncom.2024.1386841. eCollection 2024. Front Comput Neurosci. 2024. PMID: 39247252 Free PMC article. - Current insights and assumptions on α-synuclein in Lewy body disease.
Leak RK, Clark RN, Abbas M, Xu F, Brodsky JL, Chen J, Hu X, Luk KC. Leak RK, et al. Acta Neuropathol. 2024 Aug 14;148(1):18. doi: 10.1007/s00401-024-02781-3. Acta Neuropathol. 2024. PMID: 39141121 Free PMC article. Review. - Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.
Lázaro DF, Lee VM. Lázaro DF, et al. Neuron. 2024 Sep 25;112(18):3029-3042. doi: 10.1016/j.neuron.2024.05.017. Epub 2024 Jun 10. Neuron. 2024. PMID: 38861985 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical